Erratum: Roux-en-Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male rats (Endocrinology (2013) 154:6 (2015-2024) DOi:10.1210/en.2012-2130);Roux-en-Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male rats

Endocrinology

Volumn 154, Issue 6, 2013, Pages 2015-2024

  Stemmer, Kerstin ^a   Bielohuby, Maximilian ^b   Grayson, Bernadette E ^c   Begg, Denovan P ^c   Chambers, Adam P ^c   Neff, Christina ^a   Woods, Stephen C ^c   Erben, Reinhold G ^d   Tschöp, Matthias H ^a   Bidlingmaier, Martin ^b   Clemens, Thomas L ^e   Seeley, Randy J ^c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF CINCINNATI   (United States)

^d UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; GASTRIC INHIBITORY POLYPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY WEIGHT; BONE MASS; BONE METABOLISM; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENERGY METABOLISM; FOOD INTAKE; GLUCOSE TOLERANCE; INTESTINE; LIPID ABSORPTION; MALABSORPTION; MALE; NONHUMAN; OSTEOLYSIS; POSTPRANDIAL STATE; PRIORITY JOURNAL; RAT; SLEEVE GASTRECTOMY; STOMACH BYPASS; STOMACH PH; WEIGHT REDUCTION;

EID: 84878454413     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2016-1176     Document Type: Erratum

References (59)

1. World Health Organization. Obesity and Overweight. Fact Sheet 311. Geneva, Switzerland: World Health Organization; 2006.
2. Torgerson JS, Hauptman J, Boldrin MN, Sjöström L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27:155-161. (Pubitemid 38196725)
3. Sarwer DB, von Sydow Green A, Vetter ML, Wadden TA. Behavior therapy for obesity: where are we now? Curr Opin Endocrinol Diabetes Obes. 2009;16:347-352.
4. Proietto J. Why is treating obesity so difficult? Justification for the role of bariatric surgery. Med J Aust. 2011;195:144-146.
5. Buchwald H, Oien DM. Metabolic/bariatric surgery Worldwide 2008. Obes Surg. 2009;19:1605-1611.
6. Rubino F, Schauer PR, Kaplan LM, Cummings DE. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Ann Rev Med. 2010;61:393-411.
7. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. New Eng J Med. 2012;366:1567-1576.
8. Coates PS, Fernstrom JD, Fernstrom MH, Schauer PR, Greenspan SL. Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab. 2004;89:1061-1065. (Pubitemid 38368390)
9. Mahdy T, Atia S, Farid M, Adulatif A. Effect of Roux-en Y gastric bypass on bone metabolism in patients with morbid obesity: Mansoura experiences. Obes Surg. 2008;18:1526-1531.
10. Johnson JM, Maher JW, DeMaria EJ, Downs RW, Wolfe LG, Kellum JM. The long-term effects of gastric bypass on vitamin D metabolism. Ann Surg. 2006;243:701-704; discussion 704-705.
11. El-Kadre LJ, Rocha PR, de Almeida Tinoco AC, Tinoco RC. Calcium metabolism in pre- and postmenopausal morbidly obese womenat baseline and after laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2004;14:1062-1066. (Pubitemid 39299731)
12. Bal BS, Finelli FC, Shope TR, Koch TR. Nutritional deficiencies after bariatric surgery. Nat Rev Endocrinol. 2012;8:544-556.
13. Bruno C, Fulford AD, Potts JR, et al. Serum markers of bone turnover are increased at six and 18 months after Roux-en-Y bariatric surgery: correlation with the reduction in leptin. J Clin Endocrinol Metab. 2010;95:159-166.
14. Aasheim ET, Björkman S, Søvik TT, et al. Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch. Am J Clin Nutr. 2009;90:15-22.
15. Madan AK, Orth WS, Tichansky DS, Ternovits CA. Vitamin and trace mineral levels after laparoscopic gastric bypass. Obes Surg. 2006;16:603-606. (Pubitemid 43781045)
16. Ducloux R, Nobécourt E, Chevallier JM, Ducloux H, Elian N, Altman JJ. Vitamin D deficiency before bariatric surgery: should supplement intake be routinely prescribed? Obes Surg. 2011;21:556-560.
17. Ernst B, Thurnheer M, Schmid SM, Schultes B. Evidence for the necessity to systematically assess micronutrient status prior to bariatric surgery. Obes Surg. 2009;19:66-73.
18. Freire RH, Borges MC, Alvarez-Leite JI, Toulson Davisson Correia MI. Food quality, physical activity, and nutritional follow-up as determinant of weight regain after Roux-en-Y gastric bypass. Nutrition. 2012;28:53-58.
19. Cottam D, Qureshi FG, Mattar SG, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc. 2006;20:859-863. (Pubitemid 43825185)
20. Peterli R, Wölnerhanssen B, Peters T, et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg. 2009;250:234-241.
21. Chambers AP, Jessen L, Ryan KK, et al. Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. Gastroenterology. 2011;141:950-958.
22. Pluskiewicz W, Bužga M, Holéczy P, Bortlík L, Šmajstrla V, Adamczyk P. Bone mineral changes in spine and proximal femur in individual obese women after laparoscopic sleeve gastrectomy: a short-term study. Obes Surg. 2012;22:1068-1076.
23. Nogués X, Goday A, Peña MJ, et al. [Bone mass loss after sleeve gastrectomy: a prospective comparative study with gastric bypass]. Cir Esp. 2010;88:103-109.
24. Stefater MA, Perez-Tilve D, Chambers AP, et al. Sleeve gastrectomy induces loss of weight and fat mass in obese rats, but does not affect leptin sensitivity. Gastroenterology. 2010;138:2426-2436, 2436 e2421-2423.
25. Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J. 2003;17:509-511.
26. Jandacek RJ, Heubi JE, Tso P. A novel, noninvasive method for the measurement of intestinal fat absorption. Gastroenterology. 2004;127:139-144. (Pubitemid 38962282)
27. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Müller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010;25:1468-1486.
28. Bielohuby M, Popp S, Bidlingmaier M. A guide for measurement of circulating metabolic hormones in rodents: pitfalls during the pre-analyticalphase. Mol Metabol. 2012;1:47-60.
29. Bielohuby M, Stemmer K, Berger J, et al. Carbohydrate content of post-operative diet influences the effect of vertical sleeve gastrectomy on body weight reduction in obese rats. Obes Surg. 2012;22:140-151.
30. Kharitonenkov A, Shiyanova TL, Koester A, et al. FGF-21 as a novel metabolic regulator. J Clin Invest. 2005;115:1627-1635. (Pubitemid 40814671)
31. Inagaki T, Dutchak P, Zhao G, et al. Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21. Cell Metab. 2007;5:415-425. (Pubitemid 46825496)
32. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 2007;5:426-437. (Pubitemid 46825495)
33. Adams AC, Yang C, Coskun T, et al. 2012 The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue. Mol Metabol. 2013:2:31-37.
34. Wei W, Dutchak PA, Wang X, et al. Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ. Proc Natl Acad Sci USA. 2012;109:3143-3148.
35. Sipponen P, Härkönen M. Hypochlorhydric stomach: a risk condition for calcium malabsorption and osteoporosis? Scand J Gastroenterol. 2010;45:133-138.
36. Chu S, Tanaka S, Kaunitz JD, Montrose MH. Dynamic regulation of gastric surface pH by luminal pH. J Clin Invest. 1999;103:605-612. (Pubitemid 29122413)
37. Peacock M. Calcium metabolism in health and disease. Clin J Am Soc Nephrol 2010;5(suppl 1):S23-S30.
38. McDuffie JR, Calis KA, Booth SL, Uwaifo GI, Yanovski JA. Effects of orlistat on fat-soluble vitamins in obese adolescents. Pharmacotherapy. 2002;22:814-822. (Pubitemid 34743432)
39. Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA. 2005;294:1909-1917. (Pubitemid 41464692)
40. Dempster DW, Lindsay R. Pathogenesis of osteoporosis. Lancet. 1993;341:797-801. (Pubitemid 23096295)
41. Reid IR. Relationships among body mass, its components, and bone. Bone. 2002;31:547-555. (Pubitemid 35449695)
42. Cornish J, Callon KE, Bava U, et al. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol. 2002;175:405-415. (Pubitemid 35414387)
43. Ducy P, Amling M, Takeda S, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 2000;100:197-207. (Pubitemid 30064908)
44. Stunes AK, Westbroek I, Gordeladze JO, Gustafsson BI, Reseland JE, Syversen U. Systemic leptin administration in supraphysiological doses maintains bone mineral density and mechanical strength despite significant weight loss. Endocrinology. 2012;153:2245-2253.
45. Fulzele K, Riddle RC, DiGirolamo DJ, et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell. 2010;142:309-319.
46. Chambers AP, Stefater MA, Wilson-Perez HE, et al. Similar effects of roux-en-Y gastric bypass and vertical sleeve gastrectomy on glucose regulation in rats. Physiol Behav. 2011;105:120-123.
47. Tsukiyama K, Yamada Y, Yamada C, et al. Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion. Mol Endocrinol. 2006;20:1644-1651. (Pubitemid 43967571)
48. Ding KH, Shi XM, Zhong Q, et al. Impact of glucose-dependent insulinotropic peptide on age-induced bone loss. J Bone Miner Res. 2008;23:536-543. (Pubitemid 351501894)
49. Zhang M, Xuan S, Bouxsein ML, et al. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem. 2002;277:44005-44012. (Pubitemid 36157826)
50. Zhao G, Monier-Faugere MC, Langub MC, et al. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology. 2000;141:2674-2682. (Pubitemid 32269089)
51. Melmed S. Insulin-like growth factor I-a prototypic peripheralparacrine hormone? Endocrinology. 1999;140:3879-3880. (Pubitemid 30647080)
52. Oster MH, Fielder PJ, Levin N, Cronin MJ. Adaptation of the growth hormone and insulin-like growth factor-I axis to chronic and severe calorie or protein malnutrition. J Clin Invest. 1995;95:2258-2265.
53. Bielohuby M, Sawitzky M, Stoehr BJ, et al. Lack of dietary carbohydrates induces hepatic growth hormone (GH) resistance in rats. Endocrinology. 2011;152:1948-1960.
54. Folli F, Sabowitz BN, Schwesinger W, Fanti P, Guardado-Mendoza R, Muscogiuri G. Bariatric surgery and bone disease: from clinical perspective to molecular insights. Int J Obes (Lond). 2012;36:1373- 1379.
55. Marcus CS, Lengemann FW. Absorption of Ca45 and Sr85 from solid and liquid food at various levels of the alimentary tract of the rat. J Nutr. 1962;77:155-160.
56. Cramer CF, Copp DH. Progress and rate of absorption of radiostrontium through intestinal tracts of rats. Proc Soc Exp Biol Med. 1959;102:514-517.
57. Khanal RC, Nemere I. Regulation of intestinal calcium transport. Annu Rev Nutr. 2008;28:179-196.
58. Mulligan GB, Licata A. Taking vitamin D with the largest meal improves absorption and results in higher serum levels of 25-hydroxyvitamin D. J Bone Miner Res. 2010;25:928-930.
59. Heber D, Greenway FL, Kaplan LM, Livingston E, Salvador J, Still C. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:4823-4843.